| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 11/09/2000 | WO2000037489A3 Fragment of the gylcoprotein cd55/daf for producing highly effective anti-tumour medicaments and method for using the same |
| 11/09/2000 | WO2000036091A3 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells |
| 11/09/2000 | WO2000035473A3 Methods for detection and use of differentially expressed genes in disease states |
| 11/09/2000 | WO2000034652A3 Methods of identifying point mutations in a genome |
| 11/09/2000 | WO2000034477A3 Neuron-associated proteins |
| 11/09/2000 | WO2000034447A3 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 11/09/2000 | WO2000034438A3 Method for constructing libraries of phenotypic profiles |
| 11/09/2000 | WO2000032794A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 11/09/2000 | WO2000032624A3 Uncoupling protein 5 - ucp5 |
| 11/09/2000 | WO2000031306A3 Multiplex amplification of short tandem repeat loci |
| 11/09/2000 | WO2000030671A3 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto |
| 11/09/2000 | WO2000029621A3 Method for measuring target polynucleotides and novel asthma biomolecules |
| 11/09/2000 | WO2000029617A3 Water-soluble luminescent quantum dots and bioconjugates thereof |
| 11/09/2000 | WO2000029564A3 Human glycine transporter type 2 |
| 11/09/2000 | WO2000028034A3 Cytokine signal regulators |
| 11/09/2000 | WO2000027999A9 Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices |
| 11/09/2000 | WO2000027422A3 Methods and compositions for treating or preventing peripheral neuropathies |
| 11/09/2000 | WO2000026381A3 High fidelity thermostable ligase and uses thereof |
| 11/09/2000 | WO2000024765A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 11/09/2000 | WO2000023565A3 Novel neuropilin/growth factor binding and uses thereof |
| 11/09/2000 | WO2000020638A3 Methods and compositions for the diagnosis and therapy of prostate cancer |
| 11/09/2000 | WO2000015826A3 Leptin induced genes |
| 11/09/2000 | WO2000015785A3 GENE MODIFICATION IN THE GENE FOR THE DIE Gβ3-SUB-UNIT OF HUMAN G-PROTEIN |
| 11/09/2000 | WO2000008209A3 Nucleic acids encoding human tbc-1 protein and polymorphic markers thereof |
| 11/09/2000 | WO2000006737A8 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 11/09/2000 | WO2000004193A9 Method for detecting nucleic acids using target-mediated ligation of bipartite primers |
| 11/09/2000 | WO2000004050A3 Neurotrophic growth factor |
| 11/09/2000 | DE19920611A1 Modifying, cloning or amplifying cDNA comprises performing first strand synthesis in the presence of magnesium and manganese ions |
| 11/09/2000 | DE19919121A1 Multimeric cytomegalovirus antigen useful as an immunoassay reagent, and which comprises at least two p52 peptide sequences |
| 11/09/2000 | CA2742143A1 2-3-dihydroxypropyl 12-(7-nirobenzo[1,2,3]oxadiazol-4-ylamino)dodecanoates and a process for the preparation thereof |
| 11/09/2000 | CA2718662A1 Rapid and efficient capture of dna from sample without using cell lysing reagent |
| 11/09/2000 | CA2377131A1 Anti-microbial agents, diagnostic reagents, and vaccines based on unique apicomplexan parasite components |
| 11/09/2000 | CA2373227A1 Growth hormone-regulatable brown adipose tissue genes and proteins and uses thereof |
| 11/09/2000 | CA2373021A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 11/09/2000 | CA2373018A1 Novel cellular regulation factor tto 20 |
| 11/09/2000 | CA2372946A1 Asialocytokines and treatment of liver disease |
| 11/09/2000 | CA2372923A1 Dna encoding snorf36a and snorf36b receptors |
| 11/09/2000 | CA2372907A1 Zymogen activation system |
| 11/09/2000 | CA2372190A1 Methods for the treatment of neuronal atrophy-associated dementia |
| 11/09/2000 | CA2372022A1 Traf5 knockout mouse |
| 11/09/2000 | CA2371768A1 Method of screening for drugs useful in treating alzheimer's disease |
| 11/09/2000 | CA2371596A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof |
| 11/09/2000 | CA2371421A1 Method for inhibiting cell functioning for use in anti-inflammatory and anti-tumour therapies |
| 11/09/2000 | CA2371260A1 Materials and methods relating to neuronal development |
| 11/09/2000 | CA2371032A1 Neisseria genomic sequences and methods of their use |
| 11/09/2000 | CA2370821A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 11/09/2000 | CA2370261A1 Process to create biomolecule arrays on metal surfaces |
| 11/09/2000 | CA2370177A1 Methods for the identification of compounds for the treatment of alzheimer's disease |
| 11/09/2000 | CA2370134A1 Growth hormone-regulatable liver genes and proteins, and uses thereof |
| 11/09/2000 | CA2370119A1 Indicators of altered mitochondrial function in predictive methods for determining risk of type 2 diabetes mellitus |
| 11/09/2000 | CA2370117A1 Method of detection of cytochrome b mutations in funghi leading to resistance against anti-fungal agents |
| 11/09/2000 | CA2370111A1 Optical probes and assays |
| 11/09/2000 | CA2370108A1 System and method for screening of nasopharyngeal carcinoma |
| 11/09/2000 | CA2369964A1 Pesticidal fusions |
| 11/09/2000 | CA2369830A1 Methods, compositions and kits for biological indicator of sterilization |
| 11/09/2000 | CA2369363A1 Device for rapid dna sample processing with integrated liquid handling, thermocycling, and purification |
| 11/09/2000 | CA2368581A1 Detection using degradation of a tagged sequence |
| 11/09/2000 | CA2368194A1 Adeno-associated virus-delivered ribozyme compositions and methods of use |
| 11/09/2000 | CA2365590A1 Herbicide resistant plants |
| 11/09/2000 | CA2365440A1 Human ion channel proteins |
| 11/09/2000 | CA2335590A1 Algorithmic testing in laboratory medicine |
| 11/08/2000 | EP1050588A1 A device for performing an assay, use of a membrane in the manufacture of said device, kit comprising said device and method for the detection of an analyte using such device |
| 11/08/2000 | EP1050587A2 Generation and amplification of nucleic acids from ribonucleic acids |
| 11/08/2000 | EP1050584A1 Recombinant lysophosphatidic acid phosphatase |
| 11/08/2000 | EP1050581A1 Method for detecting acetyltransferase and deacetylase activities and method for screening inhibitors or accelerators of these enzymes |
| 11/08/2000 | EP1049933A1 Measurement of hydride using chemiluminescent acridinium compounds |
| 11/08/2000 | EP1049810A2 INHIBITION OF DNA MODULATION CAUSED BY MUTATED p53 |
| 11/08/2000 | EP1049809A2 EF-Tu mRNA AS A MARKER FOR VIABILITY OF BACTERIA |
| 11/08/2000 | EP1049808A1 Force discrimination assay |
| 11/08/2000 | EP1049807A1 Microparticles with multiple fluorescent signals |
| 11/08/2000 | EP1049806A1 Method for detection of nucleic acid target sequences involving in vitro transcription from an rna promoter |
| 11/08/2000 | EP1049805A2 Assay for predicting the angiographic response to lipid-lowering therapy in patients |
| 11/08/2000 | EP1049804A1 Sample buffer and methods for high resolution gel electrophoresis of denatured nucleic acids |
| 11/08/2000 | EP1049803A1 Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction |
| 11/08/2000 | EP1049802A1 Fluorimetric detection system of a nucleic acid |
| 11/08/2000 | EP1049801A1 Method for isolating and purifying nucleic acids on surfaces |
| 11/08/2000 | EP1049800A1 Asthma related genes |
| 11/08/2000 | EP1049799A1 Antimicrobial compounds |
| 11/08/2000 | EP1049798A1 Antibiotic sensitivity testing |
| 11/08/2000 | EP1049797A1 Regulation of fungal gene expression |
| 11/08/2000 | EP1049796A1 Methods for the simultaneous identification of novel biological targets and lead structures for drug development |
| 11/08/2000 | EP1049789A1 An autoregulatory system for validating microbial genes as possible antimicrobial targets using a tetracycline-controllable element |
| 11/08/2000 | EP1049781A1 Human chemokine and its use for detection and treatment of breast disease |
| 11/08/2000 | EP1049780A1 Adenine nucleotide translocator (ant) fusion proteins and uses thereof |
| 11/08/2000 | EP1049776A1 Phagocytosis genes and uses thereof |
| 11/08/2000 | EP1049775A1 Human btrcp protein |
| 11/08/2000 | EP1049774A2 Promoter regions of the mouse and human telomerase rna component genes |
| 11/08/2000 | EP1049770A1 Secreted proteins and polynucleotides encoding them |
| 11/08/2000 | EP1049744A1 Asymmetric cyanine dye quenchers |
| 11/08/2000 | EP1049714A1 Secreted proteins and polynucleotides encoding them |
| 11/08/2000 | EP1049678A2 Cyclohexyl and heterocyclyl nucleoside derivatives, method for producing these derivatives, and the use of the derivatives and their oligomers or conjugates in pairing and/or testing systems |
| 11/08/2000 | EP1049488A1 METHOD OF AND COMPOSITIONS FOR IMMUNIZATION WITH THE $i(PSEUDOMONAS) V ANTIGEN |
| 11/08/2000 | EP1049475A1 KINESIN MOTOR MODULATORS DERIVED FROM THE MARINE SPONGE $i(ADOCIA) |
| 11/08/2000 | EP1049465A1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer |
| 11/08/2000 | EP0922266B1 Process for the determination of significant anomalies in cell growth |
| 11/08/2000 | EP0910662B1 Methods and reagents for typing hla class i genes |
| 11/08/2000 | EP0812422B1 Process and compounds for use in detecting analytes by measurement of residual magnetism, and the use of the said compounds |
| 11/08/2000 | EP0755456B1 A rapid microbiological test for the detection of antibacterial compounds |
| 11/08/2000 | EP0745140B1 Circularizing nucleic acid probe able to interlock with a target sequence through catenation |
| 11/08/2000 | EP0721512B1 Quick biochemical oxygen demand test and apparatus for the same |